source
- Lilly strikes second partnership this year for recombinase-based gene editingDecades before CRISPR gene editing was invented, scientists tried to manipulate genes with enzymes called recombinases. The proteins were precise but proved tricky to use because they were hardwire…Endpoints · 3mo ago↗ source
- Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionCoultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune disea…Endpoints · 3mo ago↗ source
- Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingNovartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to s…